Plantarflexor PAS - Stroke (PAS - Stroke)
Stroke, Hemiparesis, Gait Dysfunction
About this trial
This is an interventional other trial for Stroke focused on measuring stroke, adult, gait, neuroplasticity
Eligibility Criteria
Inclusion Criteria:
- hemiparesis resulting from stroke
- single, unilateral, hemispheric stroke (cortical or sub-cortical areas)
- stroke confirmed by neuroimaging (CT or MRI)
- stroke 3 months prior to enrollment
- ability to walk, independently at least 25' on level ground, even if requiring brace or assistive device (cane)
- Veteran Status prioritized
Exclusion Criteria:
- lower extremity pain affecting ability to bear weight on legs
- contractures limiting normal range of motion in major lower extremity joints
- other neurological conditions (e.g., Parkinson's Disease, Multiple Sclerosis, ALS), prior traumatic brain injury, severe osteoarthritis or prior pathological fracture
- cardiovascular conditions contraindicative to walking or light exercise
- severe hypertension (i.e., >200/110 at rest that cannot be controlled in resting range of 180/110 mmHg)
- perceptual or cognitive deficits affecting ability to: comprehend, follow three step directions, or provide consent
Sites / Locations
- Martinez Outpatient Clinic and Community Living Center, Martinez, CA
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Other
Other
Order 1
Order 2
Order 3
All participants will receive PAS in three experimental conditions, randomized to the order of condition. Experimental order will be counterbalanced across participants. Order 1 will be: Seated@Rest, Seated@Active, Walking.
All participants will receive PAS in three experimental conditions, randomized to the order of condition. Experimental order will be counterbalanced across participants. Order 2 will be: Seated@Active, Walking, Seated@Rest.
All participants will receive PAS in three experimental conditions, randomized to the order of condition. Experimental order will be counterbalanced across participants. Order 3 will be: Walking, Seated@Rest, Seated@Active.